Search Results 71-80 of 27353 for colitis
The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...
... ulcerative colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... colon, which had developed several sites with precancerous cells related to his ulcerative colitis, which was first diagnosed in 1997. Scott had previously ...
This type of inflammatory bowel disease affects the innermost lining of your digestive tract. Learn about available treatments for this often exhausting ...
This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.
The purpose of this study is to evaluate safety and efficacy of risankizumab in subjects with ulcerative colitis (UC) in subjects who responded to induction ...
... colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis. Has received any of the following for the treatment of ...
Make your tax-deductible gift and be part of the cutting-edge research and care that's changing medicine. Donate.
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Overview · Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.